{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:22:30Z","timestamp":1790572950755,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["TR001456"],"award-info":[{"award-number":["TR001456"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015516","name":"Revance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013928","name":"National Spasmodic Dysphonia Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010987","name":"American Neurological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008537","name":"Benign Essential Blepharospasm Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008440","name":"International Parkinson and Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014425","name":"Acorda Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS116025"],"award-info":[{"award-number":["NS116025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS065701"],"award-info":[{"award-number":["NS065701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.parkreldis.2021.10.031","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T11:45:14Z","timestamp":1636544714000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The emerging neurological spectrum of AARS2-associated disorders"],"prefix":"10.1016","volume":"93","author":[{"given":"Sahyli Perez","family":"Parra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan H.","family":"Heckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-0377","authenticated-orcid":false,"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin David","family":"Mcknight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Jinnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.10.031_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajhg.2011.04.006","article-title":"Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy","volume":"88","author":"Gotz","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fgene.2015.00021","article-title":"Structural modeling of tissue-specific mitochondrial alanyl-tRNA synthetase (AARS2) defects predicts differential effects on aminoacylation","volume":"6","author":"Euro","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp-2018-319481","article-title":"Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era","volume":"90","author":"Lynch","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s10038-019-0660-y","article-title":"Identification of extremely rare mitochondrial disorders by whole exome sequencing","volume":"64","author":"Seo","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib5","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/ajmg.a.61188","article-title":"Expansion of the clinical spectrum associated with AARS2-related disorders","volume":"179","author":"Srivastava","year":"2019","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib6","first-page":"100782","article-title":"Case report: 'AARS2 leukodystrophy","volume":"28","author":"Axelsen","year":"2021","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib7","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/WNL.0000000000000497","article-title":"Novel (ovario) leukodystrophy related to AARS2 mutations","volume":"82","author":"Dallabona","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/jhg.2016.64","article-title":"The first Japanese case of leukodystrophy with ovarian failure arising from novel compound heterozygous AARS2 mutations","volume":"61","author":"Hamatani","year":"2016","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/jhg.2016.126","article-title":"Novel AARS2 gene mutation producing leukodystrophy: a case report","volume":"62","author":"Szpisjak","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamaneurol.2016.2229","article-title":"Analysis of mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"73","author":"Lynch","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib11","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1212\/NXG.0000000000000135","article-title":"Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy","volume":"3","author":"Lakshmanan","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib12","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/ene.13245","article-title":"Two Korean siblings with recently described ovarioleukodystrophy related to AARS2 mutations","volume":"24","author":"Lee","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3988\/jcn.2018.14.3.420","article-title":"Alanyl-tRNA synthetase 2-related dementia with elective bilateral frontal cystic leukoencephalopathy","volume":"14","author":"Carle","year":"2018","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s10038-018-0446-7","article-title":"An adolescence-onset male leukoencephalopathy with remarkable cerebellar atrophy and novel compound heterozygous AARS2 gene mutations: a case report","volume":"63","author":"Dong","year":"2018","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ane.12954","article-title":"AARS2-related ovarioleukodystrophy: clinical and neuroimaging features of three new cases","volume":"138","author":"Taglia","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jnen\/nly087","article-title":"AARS2 compound heterozygous variants in a case of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia","volume":"77","author":"Wang","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13816810.2017.1350723","article-title":"Retinopathy and optic atrophy: expanding the phenotypic spectrum of pathogenic variants in the AARS2 gene","volume":"39","author":"Peragallo","year":"2018","journal-title":"Ophthalmic Genet."},{"issue":"10","key":"10.1016\/j.parkreldis.2021.10.031_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s10038-019-0648-7","article-title":"A novel compound heterozygous mutation in AARS2 gene (c.965 G > A, p.R322H; c.334 G > C, p.G112R) identified in a Chinese patient with leukodystrophy involved in brain and spinal cord","volume":"64","author":"Song","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.582","article-title":"AARS2 leukoencephalopathy: a new variant of mitochondrial encephalomyopathy","volume":"7","author":"Tang","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4103\/0028-3886.263237","article-title":"Adult-onset leukodystrophy with homozygous AARS2 mutation located in the aminoacylation domain","volume":"67","author":"Uzun","year":"2019","journal-title":"Neurol. India"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1313","article-title":"A homozygous mutation of alanyl-transfer RNA synthetase 2 in a patient of adult-onset leukodystrophy: a case report and literature review","volume":"9","author":"Wang","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3389\/fneur.2019.01321","article-title":"Novel alanyl-tRNA synthetase 2 pathogenic variants in leukodystrophies","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.fertnstert.2019.05.005","article-title":"Novel alanyl-tRNA synthetase 2 (AARS2) homozygous mutation in a consanguineous Chinese family with premature ovarian insufficiency","volume":"112","author":"Zhou","year":"2019","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mdc3.12991","article-title":"New AARS2 mutations in two siblings with tremor, downbeat nystagmus, and primary amenorrhea: a benign phenotype without leukoencephalopathy","volume":"7","author":"De Michele","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib25","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1007\/s11033-020-05425-3","article-title":"Mutations in aARS genes revealed by targeted next-generation sequencing in patients with mitochondrial diseases","volume":"47","author":"Felhi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.parkreldis.2021.10.031_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12311-019-01080-y","article-title":"Alanyl-tRNA synthetase 2 (AARS2)-related ataxia without leukoencephalopathy","volume":"19","author":"Kuo","year":"2020","journal-title":"Cerebellum"},{"key":"10.1016\/j.parkreldis.2021.10.031_bib27","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCGEN.120.003086","article-title":"Recessive inheritance of a rare variant in the nuclear mitochondrial gene for AARS2 in late-onset dilated cardiomyopathy","volume":"13","author":"Nielsen","year":"2020","journal-title":"Circ Genom Precis Med"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:39:32Z","timestamp":1778600372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021003941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"alternative-id":["S1353802021003941"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.10.031","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging neurological spectrum of AARS2-associated disorders","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}